To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
The Office of Faculty Affairs and Professional Development at Wayne State University’s (WSU) School of Medicine annually recognizes faculty who have made outstanding contributions in teaching, mentoring, research, and leadership. This year, several Barbara Ann Karmanos Cancer Institute faculty, researchers, and medical staff at the Karmanos Cancer Center received these awards, highlighting their significant contributions to education and more. Others received promotions and tenure at Wayne State. School...
Hour Detroit’s 2023 Top Docs List is out; over 30 physicians from the Barbara Ann Karmanos Cancer Institute are listed. Each year, Hour Detroit Magazine puts out an online peer-to-peer review survey conducted by Professional Research Services (PRS) to determine the top physicians in southeastern Michigan. Participating physicians in Wayne, Oakland, Macomb, Washtenaw, and Livingston Counties nominate the best doctors in each field. This year’s list also includes a feature with George Yo...
Pharmacy Times Ira Winer, M.D., Ph.D. , gynecologic oncologist and member of the Gynecologic Oncology and Phase 1 Clinical Trials Multidisciplinary Teams at Karmanos, authors a piece discussing results of the first-in-human trial of sudocetaxel zendusortide, a phase 1 clinical trial that Karmanos participated in. Read the article here .